癌症2018，Vol.37Issue(5)：179-187,9.
羟考酮/纳洛酮控释片与羟考酮控释片治疗韩国癌性疼痛患者的疗效及安全性的随机对照研究
Kyung-He Lee 1Min Kyoung Kim 1Yong Sang Hong 2Jeong Eun Kim 2Gyeong-Won Lee 3TaeWon Kim 2Jung-Hun Kang 4Jin-Soo Kim 3Jin-Seok Ahn 5Sun-Young Kim 6Hwan-Jung Yun 7Young-Jun Eum 8Sung Ae Koh9
作者信息
- 1. Department of Hematology-Oncology, Yeungnam University Medical Center, Daegu 42415, South Korea.
- 2. Department of Oncology, Asan Medical Center, University of Ulsan, Seoul 05505, South Korea.
- 3. Department of Hematology-Oncology, Gyeongsang National University Hospital, Jinju 52727, South Korea.
- 4. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Pungnap-dong, Songpa-gu, Seoul 138-736, South Korea.
- 5. Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul 07061, South Korea.
- 6. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul 06351, South Korea.
- 7. Department of Hematology-Oncology, National Cancer Center, Ilsan 10408, South Korea.
- 8. Department of Hematology-Oncology, Chungnam National University Hospital, Daejeon 35015, South Korea.
- 9. Medical Affairs, Mundipharma Korea Ltd, Seoul 04637, South Korea.
- 折叠
引用本文复制引用
Kyung-He Lee,Min Kyoung Kim,Yong Sang Hong,Jeong Eun Kim,Gyeong-Won Lee,TaeWon Kim,Jung-Hun Kang,Jin-Soo Kim,Jin-Seok Ahn,Sun-Young Kim,Hwan-Jung Yun,Young-Jun Eum,Sung Ae Koh..羟考酮/纳洛酮控释片与羟考酮控释片治疗韩国癌性疼痛患者的疗效及安全性的随机对照研究[J].癌症,2018,37(5):179-187,9.基金项目
本研究得到了Mundipharma Korea Ltd.的资金支持. （）
